CDNA microarray analysis of pigment epithelium-derived factor-regulated gene expression profile in prostate carcinoma cells

International Journal of Urology

Volumn 16, Issue 3, 2009, Pages 323-328

  Liu, Weiwei ^a   Wu, Zhong ^a   Guan, Ming ^a   Lu, Yuan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Microarray; Pigment epithelium derived factor; Prostate cancer

Indexed keywords

ANGIOGENESIS INHIBITOR; BRAIN SPECIFIC ANGIOGENESIS INHIBITOR 2; COMPLEMENTARY DNA; DIMETHYL SULFOXIDE; FIBROBLAST GROWTH FACTOR 3; GLYCOPROTEIN; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; NEUROPILIN 1; PIGMENT EPITHELIUM DERIVED FACTOR; RNA; TERATOCARCINOMA DERIVED GROWTH FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CATALYSIS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GROWTH DISORDER; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

BLOTTING, WESTERN; CELL LINE, TUMOR; DNA, COMPLEMENTARY; EYE PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROARRAY ANALYSIS; NERVE GROWTH FACTORS; PROBABILITY; PROSTATE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SERPINS;

EID: 62149099498     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02199.x     Document Type: Article

References (35)

1. Duh EJ, Yang HS, Suzuma I et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Vis. Sci. 2002 43 : 821 9.
2. Gehlbach P, Demetriades AM, Yamamoto S et al. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther. 2003 10 : 637 46.
3. Guan M, Yam HF, Su B et al. Loss of pigment epithelium-derived factor expression in glioma progression. J. Clin. Pathol. 2003 56 : 277 82.
4. Abe R, Shimizu T, Yamagishi S et al. Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am. J. Pathol. 2004 164 : 1225 32.
5. Mahtabifard A, Merritt RE, Yamada RE, Crystal RG, Korst RJ. In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies. J. Thorac. Cardiovasc. Surg. 2003 126 : 28 38.
6. Wang L, Schmitz V, Perez-Mediavilla A, Izal I, Prieto J, Qian C. Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor. Mol. Ther. 2003 8 : 72 9.
7. Matsumoto K, Ishikawa H, Nishimura D, Hamasaki K, Nakao K, Eguchi K. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma. Hepatology 2004 40 : 252 9.
8. Uehara H, Miyamoto M, Kato K, Ebihara Y, Kaneko H, Hashimoto H et al. Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res. 2004 64 : 3533 7.
9. Guan M, Pang CP, Yam HF, Cheung KF, Liu WW, Lu Y. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther. 2004 11 : 325 32.
10. Halin S, Wikstrom P, Rudolfsson SH et al. Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors. Cancer Res. 2004 64 : 5664 71.
11. Doll JA, Stellmach VM, Bouck NP et al. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat. Med. 2003 9 : 774 80.
12. Isaacs JT. The biology of hormone refractory prostate cancer. Why does it develop? Urol. Clin. North Am. 1999 26 : 263 73.
13. Oh WK, Kantoff PW. Management of hormone refractory prostate cancer: Current standards and future prospects. J. Urol. 1998 160 : 1220 9.
14. Ishibashi K, Imai M. Prospect of a stanniocalcin endocrine/paracrine system in mammals. Am. J. Physiol. Renal Physiol. 2002 282 : F367 7.
15. Yamamura J, Miyoshi Y, Tamaki Y et al. mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers. Cancer Sci. 2004 95 : 887 92.
16. Gagliardi AD, Kuo EY, Raulic S, Wagner GF, DiMattia GE. Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs. Am. J. Physiol. Endocrinol. Metab. 2005 288 : E92 105.
17. Saloman DS, Bianco C, Ebert AD et al. The EGF-CFC family: Novel epidermal growth factor-related proteins in development and cancer. Endocr. Relat. Cancer 2000 7 : 199 226.
18. Kannan S, De Santis M, Lohmeyer M et al. Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J. Biol. Chem. 1997 272 : 3330 5.
19. Ebert AD, Wechselberger C, Nees M et al. Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells. Exp. Cell Res. 2000 257 : 223 9.
20. Chua SS, Ma ZQ, Gong L, Lin SH, DeMayo FJ, Tsai SY. Ectopic expression of FGF-3 results in abnormal prostate and Wolffian duct development. Oncogene 2002 21 : 1899 908.
21. Stellmach V, Crawford SE, Zhou W, Bouck N. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc. Natl. Acad. Sci. U. S. A. 2001 98 : 2593 7.
22. Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T, Imaizumi T. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci. 2005 77 : 3231 41.
23. Smith ML, Ford JM, Hollander MC et al. p53-mediated DNA repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol. Cell Biol. 2000 20 : 3705 14.
24. Maeda T, Hanna AN, Sim AB, Chua PP, Chong MT, Tron VA. GADD45 regulates G2/M arrest, DNA repair, and cell death in keratinocytes following ultraviolet exposure. J. Invest. Dermatol. 2002 119 : 22 6.
25. Dawson DW, Volpert OV, Gillis P et al. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 1999 285 : 245 8.
26. Kee HJ, Koh JT, Kim MY et al. Expression of brain-specific angiogenesis inhibitor 2 (BAI2) in normal and ischemic brain: Involvement of BAI2 in the ischemia-induced brain angiogenesis. J. Cereb. Blood Flow Metab. 2002 22 : 1054 67.
27. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998 92 : 735 45.
28. Stephenson JM, Banerjee S, Saxena NK, Cherian R, Banerjee SK. Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: A possible marker for the progression of breast cancer. Int. J. Cancer 2002 101 : 409 14.
29. Straume O, Akslen LA. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma. Angiogenesis 2003 6 : 295 301.
30. Parikh AA, Fan F, Liu WB et al. Neuropilin-1 in human colon cancer: Expression, regulation, and role in induction of angiogenesis. Am. J. Pathol. 2004 164 : 2139 51.
31. Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 2000 14 : 2532 9.
32. Blancher C, Harris AL. The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target. Cancer Metastasis Rev. 1998 17 : 187 94.
33. Acker T, Diez-Juan A, Aragones J et al. Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell. 2005 8 : 131 41.
34. Guan M, Jiang H, Xu C, Xu R, Chen Z, Lu Y. Adenovirus-mediated PEDF expression inhibits prostate cancer cell growth and results in augmented expression of PAI-2. Cancer Biol. Ther. 2007 6 : 419 25.
35. Zhang T, Guan M, Xu C, Chen Y, Lu Y. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Life Sci. 2007 81 : 1256 63.